Evidence map›Paper›PMID 37842805›Full record

ReviewMolecular systems biology2023

Enablers and challenges of spatial omics, a melting pot of technologies.

Theodore Alexandrov, Julio Saez-Rodriguez, Sinem K Saka

Abstract readReview
In one paragraph

Review in Molecular systems biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Decoding the breast cancer microenvironment by spatial multi-omics: from architecture to clinical translation.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Spatial architecture of development and disease.Nature reviews. Genetics · 2026
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Identifying Key Questions and Challenges in Microchimerism Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Theodore AlexandrovStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0001-9464-6125
Julio Saez-RodriguezMolecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0002-8552-8976
Sinem K SakaGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0002-5017-379X

Funding

EC | ERC | HORIZON EUROPE European Research Council (ERC) 101101077EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC) 773098Michael J. Fox Foundation for Parkinson's Research (MJFF)Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
6 · The paper itself

Abstract

Spatial omics has emerged as a rapidly growing and fruitful field with hundreds of publications presenting novel methods for obtaining spatially resolved information for any omics data type on spatial scales ranging from subcellular to organismal. From a technology development perspective, spatial omics is a highly interdisciplinary field that integrates imaging and omics, spatial and molecular analyses, sequencing and mass spectrometry, and image analysis and bioinformatics. The emergence of this field has not only opened a window into spatial biology, but also created multiple novel opportunities, questions, and challenges for method developers. Here, we provide the perspective of technology developers on what makes the spatial omics field unique. After providing a brief overview of the state of the art, we discuss technological enablers and challenges and present our vision about the future applications and impact of this melting pot.

Indexed as

GenomicsProteomicsComputational BiologyMass SpectrometryMetabolomicsgenomicsmetabolomicsproteomicsspatial omicstranscriptomics

Identifiers

PMID37842805
PMCPMC10632737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.